Neurocognitive and functional assessment of patients with brain metastases: A pilot study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 3, 2003, Pages 273-279

  Herman, Mary A ^a   Tremont Lukats, Ivo ^a   Meyers, Christina A ^b   Trask, Dianna D ^a   Froseth, Carrie ^a   Renschler, Markus F ^c   Mehta, Minesh P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c PHARMACYCLICS INC   (United States)

Author keywords

Brain metastases; Cancer; Clinical trials; Neurocognitive; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN CANCER; BRAIN METASTASIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGY; PATIENT COMPLIANCE; PSYCHOLOGIC TEST;

EID: 0038178937     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.COC.0000020585.85901.7C     Document Type: Article

References (37)

1. Posner JB. Intracranial metastases. Philadelphia: FA Davis, 1995.
2. Gelber RD, Larson M, Borgelt BB, et al. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981;48:1749-53.
3. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-75.
4. Weitzner MA. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest 1999;17:285-91.
5. Meyers CA, Weitzner MA. Neurobehavioral functioning and quality of life in patients treated for cancer of the central nervous system. Curr Opin Oncol 1995;7:197-200.
6. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology 1997;6:169-77.
7. Lovely MP. Quality of life of brain tumor patients. Semin Oncol Nurs 1998;14:73-80.
8. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsych 1991;5:125-42.
9. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1995.
10. Benton AL, Hamshire K. Multilingual aphasia examination. Iowa City: AJA Associates, 1989.
11. Linacre JM, Heinemann AW, Wright BD, et al. The structure and stability of the Functional Independence Measure. Arch Phys Med Rehabil 1994;75:127-32.
12. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 1996;30:61-9.
13. Lilja A, Smith GJ, Salford LG. Microprocesses in perception and personality. J Nerv Ment Dis 1992;180:82-8.
14. Hochberg FH, Slotnick B. Neuropsychologic impairment in astrocytoma survivors. Neurology 1980;30:172-7.
15. Lieberman AN, Foo SH, Ransohoff J, et al. Long term survival among patients with malignant brain tumors. Neurosurgery 1982; 10:450-3.
16. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 1990;28:818-22.
17. Archibald YM, Lunn D, Ruttan LA, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 1994;80: 247-53.
18. Taphoorn MJ, Heimans JJ, Snoek FJ, et al. Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 1992;55:372-6.
19. Salander P, Karlsson T, Bergenheim T, et al. Long-term memory deficits in patients with malignant gliomas. J Neurooncol 1995; 25:227-38.
20. Grant R, Slattery J, Gregor A, et al. Recording neurological impairment in clinical trials of glioma. J Neurooncol 1994;19:37-49.
21. DeAngelis LM, Mandell LR, Thaler HT, et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 1989;24:798-805.
22. Mackworth N, Fobair P, Prados MD. Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol 1992;14:243-53.
23. Weitzner MA, Meyers CA, Gelke CK, et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995;75:1151-61.
24. Meyers C. Issues of quality of life in neuro-oncology. In: Vecht C, editor. Handbook of clinical neurology. New York: Elsevier Science, 1997.
25. Boyd TS, Mehta MP. Stereotactic radiosurgery for brain metastases [Review]. Oncology (Huntington) 13:1397-409.
26. Choucair AK, Scott C, Urtasun R, et al. Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1997;38:9-20.
27. Osoba D, Aaronson NK, Muller M, et al. Effect of neurological dysfunction on health-related quality of life in patients with highgrade glioma. J Neurooncol 1997;34:263-78.
28. Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 1998;34:1902-9.
29. Jenkin D, Danjoux C, Greenberg M. Subsequent quality of life for children irradiated for a brain tumor before age four years. Med Pediatr Oncol 1998;31:506-11.
30. Hutter BO, Spetzger U, Bertalanffy H, et al. Cognition and quality of life in patients after transcallosal microsurgery for midline tumors. J Neurosurg Sci 1997;41:123-9.
31. Giovagnoli AR, Tamburini M, Boiardi A. Quality of life in brain tumor patients. J Neurooncol 1996;30:71-80.
32. Weitzner MA, Meyers CA, Byrne K. Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 1996;84:29-34.
33. Sachsenheimer W, Piotrowski W, Bimmler T. Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status. J Neurooncol 1992;13:177-81.
34. Kleinberg L, Wallner K, Malkin MG. Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 1993;26:129-33.
35. Leibel SA, Gutin PH, Wara WM, et al. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 1989;17:1129-39.
36. Trojanowski T, Peszynski J, Turowski K, et al. Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 1989;70:18-23.
37. Scerrati M, Montemaggi P, Iacoangeli M, et al. Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases. Acta Neurochir 1994;13:97-105.